Solid medication dosage form modification at the bedside and in the pharmacy of Queensland Hospitals

Journal of Pharmacy Practice and Research

Volumn 39, Issue 2, 2009, Pages 129-134

  Nissen, Lisa M ^a   Haywood, Alison ^b   Steadman, Kathryn J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ADALAT OROS; AMIODARONE; AMLODIPINE; ATENOLOL; DESMOPRESSIN; DIGOXIN; DOCUSATE SODIUM; FOLIC ACID; FUROSEMIDE; IRON; METOPROLOL; MORPHINE; MORPHINE SULFATE; MULTIVITAMIN; NIFEDIPINE; OMEPRAZOLE; PANTOPRAZOLE; PARACETAMOL; PERINDOPRIL; PHENOXYBENZAMINE; PROBITOR; PROPRANOLOL; RISPERIDONE; SENNA EXTRACT; SERTRALINE; SILDENAFIL; SOTALOL; SPIRONOLACTONE; TACROLIMUS; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENLAFAXINE; VERACAPS; VERAPAMIL;

ADVERSE DRUG REACTION; ARTICLE; AWARENESS; DRUG CAPSULE; DRUG DOSAGE FORM; EDUCATION; HOSPITAL; HOSPITAL BED; HOSPITAL PHARMACY; HUMAN; NURSE; PHARMACIST; PHYSICIAN; PRESCRIPTION; RURAL AREA; TABLET; UNSPECIFIED SIDE EFFECT;

EID: 68849093903     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.2055-2335.2009.tb00436.x     Document Type: Article

References (25)

1. Chui J, Tordoff J, Reith D. Changes in availability of paediatric medicines in Australia between 1998 and 2002. Br J Clin Pharmacol 2004; 59: 736-742
2. Hansen DL, Tulinius D, Hansen EH. Adolescents' struggles with swallowing tablets: barriers, strategies and learning. Pharm World Sci 2008; 30: 65-69 (Pubitemid 350172649)
3. Glass BD, Haywood A. Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products. J Pharm Pharmaceut Sci 2006; 9: 398-426. (Pubitemid 46630112)
4. Strachan I, Greener M. Medication-related swallowing difficulties may be more common than we realise. Pharm Pract 2005; 15: 411-414 (Pubitemid 41771408)
5. Cook GK, Ling JW, Lee R. Extemporaneous compounding in Queensland hospitals. J Pharm Pract Res 2007; 37: 204-207
6. Kairuz T, Chhim S, Hasan F, Kumar K, Lal A, Patel R, et al. Extemporaneous compounding in a sample of New Zealand hospitals: a retrospective survey. J N Z Med Assoc 2007; 120: 48-56.
7. Sharley NA, YuAM, Williams DB. Stability of mixtures formulated from warfarin tablets or powder. J Pharm Pract Res 2007; 37: 95-97
8. Hayward A, Mangan M, Grant G, Glass BD. Extemporaneous isoniazid mixture: stability implications. J Pharm Pract Res 2005; 35: 181-182 (Pubitemid 41564936)
9. Paradiso LM, Roughead EE, Gilbert AL, Cosh D, Nation RL, Barnes L, et al. Crushing or altering medications: what's happening in residential aged-care facilities? Aust J Ageing 2002; 21: 123-127
10. Wright D. Medication administration in nursing homes. Nurs Stand 2002; 16: 33-38
11. Mistry B, Samuel L, Bowden S, McArtney RJ, Roberts DE. Simplifying oral drug therapy for patients with swallowing difficulties. Pharm J 1995; 254: 808-9.
12. Haw C, Stubbs J, Dickens G. An observational study of medication administration errors in old-age psychiatric inpatients. Int J Qual Health Care 2007; 19: 1-7.
13. Stubbs J, Haw C, Dickens G. Dose form modification - a common but potentially hazardous practice. A literature review and study of medication administration to older psychiatric inpatients. Int Psychogeriatrics 2008; 20: 616-627
14. Queensland Health. Queensland Health district profiles. Brisbane: Queensland Health; 2008. Available from 〈ww-w.health.qld.gov.au/ wwwprofiles/default.asp〉. Accessed 25 June 2008.
15. GISCA. Pharmacy Access/Remoteness Index of Australia (PhARIA). Adelaide: GISCA; 2008. Available from 〈www.gisca.adelaide.edu.au/projects/pharia. html〉. Accessed 25 June 2008.
16. Lucas-Bouwman ME, Roorda RJ, Jansman FGA, Brand PL. Crushed prednisolone tablets or oral solution for acute asthma? Arch Dis Child 2001; 84: 347-348
17. Horn JR, Howden CW. Similarities and differences among delayed-release proton-pump inhibitor formulations. Aliment Pharmacol Ther 2005; 22 (suppl 3): 20-24 (Pubitemid 41783983)
18. Manessis A, Lascher S, Bukberg P, Darmody T, Yen V, Sadek S, et al. Quantifying amount of adsorption of levothyroxine by percutaneous endoscopic gastronomy tubes. J Parenter Enteral Nutr 2008; 32: 197-200.
19. Griffith R. Tablet crushing and the law. Pharm J 2003; 271; 90-91
20. James A. The legal and clinical implications of crushing tablet medication. Nurs Times 2004; 100: 28-29
21. Winiarski A, Infield MH, Tscheme R, Bachynsky M, Rucki R, Nagano-Mate K. Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules. J Am Pharm Assoc 2007; 47: 747-755
22. Valanis B, Vollmer W, Labuhn K, Glass A. Occupational exposure to antineoplastic agents and self-reported infertility among nurses and pharmacists. J Occup Environ Med 1997; 39: 574-580 (Pubitemid 27280106)
23. Valanis B, Vollmer W, Steele P. Occupational exposure to antineoplastic agents: self-reported miscarriages and stillbirths among nurses and pharmacists. J Occup Environ Med 1999; 41: 632-638 (Pubitemid 29382927)
24. Pharmaceutical Society of Australia. Australian pharmaceutical formulary and handbook. 20th ed. Parkville: Pharmaceutical Society of Australia; 2006.
25. Pappas A, MacPherson R, Stewart K. Extemporaneous prescribing: whatever happened to it? A survey of Australian general practitioners. J Pharm Pract Res 2002; 32: 310-314 (Pubitemid 36142284)